Immunotherapy: Open Access
Open Access

High Impact List of Articles

• Joint Action of the Nano-sized System of Small Non-coding RNAs with DDMC Vector and Recombinant IL-7 Reprograms A-549 Lung Adenocarcinoma Cells into CD4⁺ Cells
  Oxana V. Klimenko*

  Research Article: Immunotherapy: Open Access

• MicroRNAs in the Cholinergic Anti-Inflammatory Pathway: Prospective Therapeutic Targets for Inflammatory Diseases
  Yang Sun and Xia Liu

  Editorial: Immunotherapy: Open Access

• Commentary on from Bench to Bedside: A Comprehensive Review of Pancreatic Cancer Immunotherapy. Slow Improvements in Meaningful Clinical Benefit
  Paul R Kunk and Osama E Rahma

  Commentary: Immunotherapy: Open Access

• Facets of Dendritic Cell Function: Who would Think about Cardiovascular Diseases?
  Maja-Theresa Dieterlen and Markus J Barten

  Commentary: Immunotherapy: Open Access

• Early Diagnosis of Renal Tubular Dysfunction in HIV-Infected Patients; a Case of Interleukin (IL)-18 and other Common Indicators of Renal Toxicity
  Deebii N, Tamuno I, Orluwene CG, Okerengwo AA, Obunge OK, Odum EP and Oko-jaja RI

  Research Article: Immunotherapy: Open Access

Conference Proceedings

• Clinical study of hemagglutinating virus of Japan envelope against chemotherapy resistant pleural mesothelioma
  Chunmna Lee, Muneyoshi Kuroyama, Takashi Nakano, Meinoshin Okumura, Yasufumi Kaneda, Yoshihisa Kadota and Shinji Atagi

  Posters & Accepted Abstracts: Immunotherapy: Open Access

• The evaluation of concentration of calprotectin, in pleural fluid with causes of exudative pleural effusion
  Mohammad Reza Hashempour, Ali Aryannia, Mahshid Mehrjerdian, Mojtaba Kiani and Gholam Reza Roshandel

  Posters & Accepted Abstracts: Immunotherapy: Open Access

• Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T-cell signaling switch and emerging target in cancer immunotherapy
  Victoria Klepsch

  Scientific Tracks Abstracts: Immunotherapy: Open Access

• The significance of lymph node macrophages in the induction of anti-cancer immune response
  Yoshihiro Komohara

  Scientific Tracks Abstracts: Immunotherapy: Open Access

• Phase-I/IIa trial of chimeric antigen receptor modified T-cells against CD133 in patients with sorafenib refractory hepatocellular carcinoma (HCC) and other solid tumors
  Weidong Han

  Scientific Tracks Abstracts: Immunotherapy: Open Access

Relevant Topics in Immunology & Microbiology